Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial

• Main Authors: Hee-Yeon Shin (Author), Ha-Ri Kim (Author), Geon-Ho Jahng (Author), Chul Jin (Author), Seungwon Kwon (Author), Seung-Yeon Cho (Author), Seong-Uk Park (Author), Woo-Sang Jung (Author), Sang-Kwan Moon (Author), Chang-Nam Ko (Author), Jung-Mi Park (Author)
• Format: Book
• Published: BMC, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Mild cognitive impairment (MCI) is considered an intermediate phase between normal aging and dementia. As the majority of cases of amnestic MCI (aMCI) progress to Alzheimer's disease (AD), it is considered the prodromal stage of AD, and a treatment target for prevention of f...